GFACX | LGLAX | GFACX / LGLAX | |
Total Expense Ratio | 1.36 | 0.90 | 151% |
Annual Report Gross Expense Ratio | 1.36 | 0.90 | 151% |
Fund Existence | 24 years | 14 years | - |
Gain YTD | 9.426 | 7.218 | 131% |
Front Load | N/A | 6% | - |
Min. Initial Investment | 250 | 1500 | 17% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 319B | 7.36B | 4,334% |
Annual Yield % from dividends | 0.00 | 0.00 | - |
Returns for 1 year | 8.52 | 24.23 | 35% |
Returns for 3 years | 49.72 | 86.97 | 57% |
Returns for 5 years | 44.27 | 43.97 | 101% |
Returns for 10 years | 65.33 | 116.27 | 56% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RNPFX | 69.55 | 0.46 | +0.67% |
American Funds New Perspective R5 | |||
HAOYX | 22.77 | 0.11 | +0.49% |
Hartford International Opportunities Y | |||
SIIEX | 17.76 | 0.08 | +0.45% |
Touchstone International Value Y | |||
GLRBX | 22.94 | 0.04 | +0.19% |
James Balanced: Golden Rainbow R | |||
ETIHX | 34.10 | -0.05 | -0.15% |
Eventide Healthcare & Life Sciences I |